GLP1R and atrial fibrillation: Potential underlying mechanisms of treatment benefit GLP1-RA include several nonglycemic effects, such as reductions in body weight and blood pressure; anti-fibrotic effects; and improvement of microcirculation, endothelial function, and conduction properties, all of which may reduce the development of AF [52].